BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 7584502)

  • 1. Evaluation of Fc gamma receptor mediated T-cell activation by two purified CD3 x CD19 bispecific monoclonal antibodies with hybrid Fc domains.
    Haagen IA; Geerars AJ; Bast EJ; de Gast GC; van de Winkel JG; de Lau WB
    Ther Immunol; 1994 Oct; 1(5):279-87. PubMed ID: 7584502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of human monocyte Fc gamma receptors with rat IgG2b. A new indicator for the Fc gamma RIIa (R-H131) polymorphism.
    Haagen IA; Geerars AJ; Clark MR; van de Winkel JG
    J Immunol; 1995 Feb; 154(4):1852-60. PubMed ID: 7836769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of IgG FcR-mediated proliferation of human T cells induced by mouse and human anti-CD3 monoclonal antibodies. Identification of a functional polymorphism to human IgG2 anti-CD3.
    Parren PW; Warmerdam PA; Boeije LC; Capel PJ; van de Winkel JG; Aarden LA
    J Immunol; 1992 Feb; 148(3):695-701. PubMed ID: 1530954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A polymorphic Fc receptor for mouse IgG2b on human B cells and monocytes.
    Holtrop S; Rijke-Schilder GP; Koene RA; Tax WJ
    Immunology; 1991 Dec; 74(4):613-20. PubMed ID: 1838352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of T cell cytotoxicity against autologous common acute lymphoblastic leukemia (cALL) blasts by CD3xCD19 bispecific antibody.
    Csóka M; Strauss G; Debatin KM; Moldenhauer G
    Leukemia; 1996 Nov; 10(11):1765-72. PubMed ID: 8892680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Fc-region of a new class of intact bispecific antibody mediates activation of accessory cells and NK cells and induces direct phagocytosis of tumour cells.
    Zeidler R; Mysliwietz J; Csánady M; Walz A; Ziegler I; Schmitt B; Wollenberg B; Lindhofer H
    Br J Cancer; 2000 Jul; 83(2):261-6. PubMed ID: 10901380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytolysis of leukemic B-cells by T-cells activated via two bispecific antibodies.
    Bohlen H; Manzke O; Patel B; Moldenhauer G; Dörken B; von Fliedner V; Diehl V; Tesch H
    Cancer Res; 1993 Sep; 53(18):4310-4. PubMed ID: 7689932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between hybrid mouse monoclonal antibodies and the human high-affinity IgG FcR, huFc gamma RI, on U937. Involvement of only one of the mIgG heavy chains in receptor binding.
    Koolwijk P; Spierenburg GT; Frasa H; Boot JH; van de Winkel JG; Bast BJ
    J Immunol; 1989 Sep; 143(5):1656-62. PubMed ID: 2527269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-linking Fc receptors on monocytes triggers IL-6 production. Role in anti-CD3-induced T cell activation.
    Krutmann J; Kirnbauer R; Köck A; Schwarz T; Schöpf E; May LT; Sehgal PB; Luger TA
    J Immunol; 1990 Sep; 145(5):1337-42. PubMed ID: 2143517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fully human CD19/CD3 bi-specific antibody triggers potent and specific cytotoxicity by unstimulated T lymphocytes against non-Hodgkin's lymphoma.
    Zhou Y; Gou LT; Mu B; Liao WC; He J; Ma C; Yao YQ; Yang JL
    Biotechnol Lett; 2012 Jul; 34(7):1183-91. PubMed ID: 22421972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bispecific anti-idiotype/anti-CD3 antibody therapy of murine B cell lymphoma.
    Weiner GJ; Hillstrom JR
    J Immunol; 1991 Dec; 147(11):4035-44. PubMed ID: 1834746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of T cell activation in anti-CD3 x antitumor bispecific antibody therapy.
    Weiner GJ; Kostelny SA; Hillstrom JR; Cole MS; Link BK; Wang SL; Tso JY
    J Immunol; 1994 Mar; 152(5):2385-92. PubMed ID: 8133049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell unresponsiveness to the mitogenic activity of OKT3 antibody results from a deficiency of monocyte Fc gamma receptors for murine IgG2a and inability to cross-link the T3-Ti complex.
    Ceuppens JL; Bloemmen FJ; Van Wauwe JP
    J Immunol; 1985 Dec; 135(6):3882-6. PubMed ID: 2933454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of murine B cell lymphoma with bispecific monoclonal antibodies (anti-idiotype x anti-CD3).
    Demanet C; Brissinck J; Van Mechelen M; Leo O; Thielemans K
    J Immunol; 1991 Aug; 147(3):1091-7. PubMed ID: 1830596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cure of Burkitt's lymphoma in severe combined immunodeficiency mice by T cells, tetravalent CD3 x CD19 tandem diabody, and CD28 costimulation.
    Cochlovius B; Kipriyanov SM; Stassar MJ; Schuhmacher J; Benner A; Moldenhauer G; Little M
    Cancer Res; 2000 Aug; 60(16):4336-41. PubMed ID: 10969772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of T cell proliferation with anti-CD3 switch-variant monoclonal antibodies: effects of heavy chain isotype in monocyte-dependent systems.
    Van Lier RA; Boot JH; De Groot ER; Aarden LA
    Eur J Immunol; 1987 Nov; 17(11):1599-604. PubMed ID: 2960543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma restores T lymphocyte proliferation of nonresponders to IgG1 anti-CD3 via the induction of Fc gamma 1 receptors on monocytes.
    Benichou G; Kanellopoulos JM; Wallon C; Boue F; Delfraissy JF
    Eur J Immunol; 1987 Aug; 17(8):1175-81. PubMed ID: 2957217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of intracellular Ca2+ mobilization and cytotoxicity by hybrid mouse monoclonal antibodies. Fc gamma RII regulation of Fc gamma RI-triggered functions or signaling?
    Koolwijk P; Van de Winkel JG; Pfefferkorn LC; Jacobs CW; Otten I; Spierenburg GT; Bast BJ
    J Immunol; 1991 Jul; 147(2):595-602. PubMed ID: 1830069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fc receptors for mouse IgG1 on human monocytes: polymorphism and role in antibody-induced T cell proliferation.
    Tax WJ; Hermes FF; Willems RW; Capel PJ; Koene RA
    J Immunol; 1984 Sep; 133(3):1185-9. PubMed ID: 6235283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective lysis of lymphoma cells with a stabilised bispecific single-chain Fv antibody against CD19 and FcgammaRIII (CD16).
    Bruenke J; Barbin K; Kunert S; Lang P; Pfeiffer M; Stieglmaier K; Niethammer D; Stockmeyer B; Peipp M; Repp R; Valerius T; Fey GH
    Br J Haematol; 2005 Jul; 130(2):218-28. PubMed ID: 16029450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.